Skip to content

Savara SVRA Total Liabilities

Total Liabilities at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$379M+8.1%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$8.16M-93.8%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$859.67M+1.3%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$67.1M+12.6%
TRV
Trevi Therapeutics, Inc.TRVI
$7.48M-0.9%
PVL
Palvella TherapeuticsPVLA
$31.45M+31.8%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.24B+247%
Enterprise value$1.23B+235%
P/S4,808.2×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's total liabilities?
Savara (SVRA) reported total liabilities of $45.61M in Q1 2026.
How has Savara's total liabilities changed year-over-year?
Savara's total liabilities increased by 10.0% year-over-year, from $41.47M to $45.61M.
What is the long-term trend for Savara's total liabilities?
Over 5 years (2020 to 2025), Savara's total liabilities has grown at a 8.6% compound annual growth rate (CAGR), from $33.36M to $50.3M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.